THE HIGHWAY FOR ONCOLOGIC SOLUTIONS We are the digital solution based on AI, transforming care delivery by democratizing access to screening & diagnosis while providing an efficient path to treatment. Solución digital basada en IA, que transforma el sistema de salud democratizando el acceso a la detección y diagnóstico mientras brinda un camino eficiente al tratamiento.
Link externo para Mamotest
Mamotest compartilhou isso
Congrats to #Hub71 startup Mamotest for securing $1.5M from Philips Foundation Impact Investments 🚀 This funding is helping Mamotest advance its mission of bringing life-saving breast cancer diagnostics to underserved communities worldwide. Through their AI-powered technology, they’re driving global health equity and transforming patient care with innovative solutions 💡 Learn more: https://shorturl.at/peEi7 Guillermo Pepe | Nicolas Loperfido #TechEcosystem #Startups
Mamotest compartilhou isso
CEO & Founder MAMOTEST pwrd by BolderAi - AI powered platform democratizing access to breast cancer early diagnosis while providing an efficient path to treatment
🌍✨ Empowering Innovators, Transforming Lives ✨🌍 Tomorrow, Abu Dhabi will host the Zayed Sustainability Prize—a celebration of innovation and impact across the globe. This remarkable initiative has become a beacon for those who are striving to create a more sustainable and equitable world. At Mamotest, we are proud to have been past winners in the Healthcare category, an achievement that not only validated our mission but also amplified our visibility, enabling us to save lives through early breast cancer detection. Winning this prize was a game-changer, connecting us with a global network of changemakers and helping us scale our vision. The Zayed Sustainability Prize is more than just recognition; it’s a platform that empowers innovators to turn their ideas into tangible solutions that address real-world challenges. It showcases how ingenuity can inspire action and deliver impact on a global scale. To all the candidates competing tomorrow—best of luck! 🌟 Your work has already made an incredible difference, and this prize could be the stepping stone to even greater impact. Let’s continue to innovate, collaborate, and work toward a brighter, healthier, and more sustainable future. 🚀 #ZayedSustainabilityPrize #Innovation #Sustainability #HealthcareInnovation #Mamotest #Impact #AbuDhabi #UAE
We share the gratitude of the entire Mamotest team in the words of our Founder and CEO, Guillermo Pepe, for the "Visionary Leadership Best Practices Recognition 2024" awarded by the Frost & Sullivan Institute. This recognition reaffirms our commitment to patient-centered healthcare. 🩺🌟 🙌 Thank you, Frost & Sullivan Institute, for highlighting our work and inspiring us to continue innovating. Together, we are shaping a more equitable and brighter future for global healthcare. 🌍
🚀 ¡Nos complace compartir una gran noticia! Mamotest ha cerrado una nueva ronda de inversión por 1,5 millones de dólares, alcanzando un total de 7M en financiamiento. 💜 Junto a Philips Foundation Impact Investments, nuestro primer inversor europeo, con los apoyos de Merck Sharp & Dohme (MSD) y Johnson & Johnson Impact Ventures, daremos un gran paso hacia el futuro. El 2025 se viene con todo: ¡a escalar nuestro impacto y posicionar a BolderAi como un líder global en salud! 💪🏼🌎
🚀 We’re excited to share some great news! Mamotest has closed a new funding round of $1.5 million, bringing our total funding to $7M. 💜 With the support of Philips Foundation Impact Investments, our first European investor, along with Merck Sharp & Dohme (MSD) and Johnson & Johnson Impact Ventures, we’re taking a huge step towards the future. 2025 is going to be huge: we’re set to scale our impact and position BolderAi as a global leader in health! 💪🏼🌎
🚀 🚀 Guillermo Pepe
🎉 Big News from Tech4Eva Alumni - Mamotest secures $1.5M from Philips Foundation Impact Investments! This milestone brings Mamotest’s total funding to $7 million, with support from global healthcare giants, MSD Merck Sharp & Dohme A.G. and Johnson & Johnson Impact Ventures 💡 What’s Next? This funding will: ➡️ Accelerate the development of Mamotest’s AI-driven healthcare solutions ➡️ Expand operations to serve underserved populations in Argentina, Mexico, Brazil, and Spain Congratulations to Camila de Pamphilis, Guillermo Pepe and all his team! 👏 Groupe Mutuel EPFL Innovation Park #Tech4Eva #FemTech #WomensHealth #BreastCancer
🌟 ¡Sumate a Mamotest! Estamos en búsqueda de un@ Operativ@ de Diagnóstico por Imágenes (Dispatcher) 🌟 ¿Te apasiona el mundo de la salud y tienes habilidades organizativas? Entonces, ¡este puesto es para vos! En Mamotest estamos buscando un/a Operativo/a de Diagnóstico por Imágenes para trabajar de manera remota en nuestro equipo. ¿Qué vas a hacer? ✅ Recepcionar estudios de diagnóstico por imágenes enviados por instituciones de salud. ✅ Asignar estos estudios al equipo médico adecuado, asegurando tiempos de respuesta eficientes. ✅ Coordinar con los equipos médicos y administrativos para mantener el flujo de trabajo perfecto. ✅ Reportar el estado de los estudios al cliente a nivel diario y mensual. ¿Qué buscamos en vos? ✔️ Experiencia previa (no excluyente) en roles administrativos en instituciones de salud. ✔️ Conocimiento básico de diagnóstico por imágenes (¡si tienes experiencia en el área, mejor!). ✔️ Dominio avanzado del paquete Office (Excel, Word, Outlook) ¡imprescindible!. ¿Cómo es la modalidad de trabajo? 💻 Modalidad: Remoto 🕑 Horario: Part-time (de 6 a 10 hrs o de 7 a 11 hrs) 🚀 Incorporación: ¡Inmediata! Si cumples con los requisitos y te entusiasma la oportunidad, ¡queremos conocerte! Envianos tu CV junto con la remuneración pretendida a rfagalde@mamotest.com. Te esperamos! 🚀
Wishing you a happy New Year and an excellent start to 2025! ✨ We want to thank you for trusting Mamotest and being part of this incredible journey to democratize access to high-quality oncological diagnosis and treatment. 🚀 2024 has been a year of great progress, and we are ready to continue innovating and growing with even more determination. In 2025, let’s have fun and be BOLDER ! 🌟 Thank you for being with us on this journey. Together, we will continue to make a difference! 💙
Mamotest compartilhou isso
Siempre es un orgullo ver crecer y acompañar a las compañias de la red. Entre las empresas que levantaron capital en 2024, hay Emprendedores Endeavor y Alumnis ScaleUp 1. Ualá consolidó su Serie E con USD 300 millones 2. tapi levantó inversión por USD 22 millones liderada por KASZEK 3. Pomelo levantó USD 40 millones y estrenó nuevas oficinas en BA 😎 4.AVEDIAN, la startup healthtech que participó en Scale Up by Endeavor 2023, levanto USD 1 millón pre serie A 5.Kilimo, tambien parte del programa Scale Up, consolidó USD 7.5 millones en su Serie A 6. Mamotest, liderada por Guillermo Pepe, cierra el 2024 con USD 1.5 millones de capital levantado ¿Cuáles se sumarán en el 2025?👩💻
Mamotest compartilhou isso
Mamotest cierra una ronda por US$ 1,5 millones liderada por Philips Mamotest cerró una ronda de inversiones por US$ 1,5 millones, que lideró Philips Foundation Impact Investments, su primer inversor europeo. Mamotest es una empresa de tecnología en salud que está revolucionando la atención del cáncer de mama. A través de tecnología de impacto y datos del mundo real (real world data). Por su... #Salud #Negocios #Gobierno Ir a la nota: https://lnkd.in/dEdPHY3y
Última rodada
SementeUS$ 3.300.000,00